Determination of the Genotype and Phenotype of Serum Paraoxonase 1 (PON1) Status in a Group of Agricultural and Nonagricultural Workers in the Coquimbo Region, Chile

REFERENCES

• Acuna, M., Eaton, L., and Cifuentes, L. 2004. Genetic variants of the paraoxonases (PON1 and PON2) in the Chilean population. Hum. Biol. 76: 299–305.
   PubMed Web of Science ®Google Scholar
• Adkins, S., Gan, K. N., Mody, M., and La Du, B. N. 1993. Molecular-basis for the polymorphic forms of human serum paraoxonase arylesterase—Glutamine or arginine at position 191, for the respective A-allozymes or B-allozymes. Am. J. Hum. Genet. 52: 598–608.
   PubMed Web of Science ®Google Scholar
• Albers, J. W., Garabrant, D. H., Berent, S., and Richardson, R. J. 2010. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers. J. Expos. Sci. Environ. Epidemiol. 20: 79–89.
   PubMed Web of Science ®Google Scholar
• Androutsopoulos, V. P., Kanavouras, K., and Tsatsakis, A. M. 2011. Role of paraoxonase 1 (PON1) in organophosphate metabolism: Implications in neurodegenerative diseases. Toxicol. Appl. Pharmacol. 256: 418–424.
   PubMed Web of Science ®Google Scholar
• Baldi, I., Robert, C., Piantoni, F., Tual, S., Bouvier, G., Lebailly, P., and Raherison, C. 2014. Agricultural exposure and asthma risk in the AGRICAN French cohort. Int. J. Hyg. Environ. Health 217: 435–442.
   PubMed Web of Science ®Google Scholar
• Burns, C. J., McIntosh, L. J., Mink, P. J., Jurek, A. M., and Li, A. A. 2013. Pesticide exposure and neurodevelopmental outcomes: Review of the epidemiologic and animal studies. J. Toxicol. Environ. Health B 16: 127–283.
   PubMed Web of Science ®Google Scholar
• Calabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., Bernini, F., and Franceschini, G. 2004. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metab. Clin. Exp. 53: 153–158.
   PubMed Web of Science ®Google Scholar
• Chen, J., Kumar, M., Chan, W., Berkowitz, G., and Wetmur, J. G. 2003. Increased influence of genetic variation on PON1 activity in neonates. Environ. Health Perspect. 111: 1403–1409.
   PubMed Web of Science ®Google Scholar
• Costa, L. G., Cole, T. B., Jarvik, G. P., and Furlong, C. E. 2003. Functional genomic of the paraoxonase (PON1) polymorphisms: Effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54: 371–392.
   PubMed Web of Science ®Google Scholar
• Costa, L. G., Giordano, G., Cole, T. B., Marsillach, J., and Furlong, C. E. 2013. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity. Toxicology 307: 115–122.
   PubMed Web of Science ®Google Scholar
• Costa, L. G., Giordano, G., and Furlong, C. E. 2011. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on. Biochem. Pharmacol. 81: 337–344.
   PubMed Web of Science ®Google Scholar
• Costa, L. G., italone, A., Cole, T. B., and Furlong, C. E. 2005. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 69: 541–550.
   PubMed Web of Science ®Google Scholar
• Cowan, J., Sinton, C. M., Varley, A. W., Wians, F. H., Haley, R. W., and Munford, R. S. 2001. Gene therapy to prevent organophosphate intoxication. Toxicol. Appl. Pharmacol. 173: 1–6.
   PubMed Web of Science ®Google Scholar
• Davies, H. G., Richter, R. J., Keifer, M., Broomfield, C. A., Sowalla, J., and Furlong, C. E. 1996. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet 14: 334–336.
   PubMed Web of Science ®Google Scholar
• dos Santos, N. P. C., Ribeiro-dos-Santos, A. K. C., and Santos, S. E. B. 2005. Frequency of the Q192R and L55M polymorphisms of the human serum paraoxonase gene (PON1) in ten Amazonian Amerindian tribes. Genet. Mol. Biol. 28: 36–39.
   Web of Science ®Google Scholar
• Eckerson, H. W., Wyte, C. M., and La Du, B. N. 1983. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet. 35: 1126–1138.
   PubMed Web of Science ®Google Scholar
• Ferre, N., Camps, J., Fernandez-Ballart, J., Arija, V., Murphy, M. M., Ceruelo, S., Biarnes, E., Vilelle, E., Tous, M., and Joven, J. 2003. Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin. Chem. 49: 1491–1497.
   PubMed Web of Science ®Google Scholar
• Furlong, C. E. 2002. Comments on genetic and developmental variability of sensitivity to chlorpyrifos/chlorpyrifos oxon exposure as modulated by plasma paraoxonase (PON1). Comments provided to U.S EPA SAP on chlorpyrifos. http://www.epa.gov/scipoly/sap/2002/june/clorphyr.pdf
   Google Scholar
• Furlong, C. E., Richter, R. J., Seidel, S. L., and Motulsky, A. G. 1988. Role of genetic-polymorphism of human-plasma paraoxonase arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. Hum. Genet. 43: 230–238.
   PubMed Web of Science ®Google Scholar
• Furlong, C. E., Suzuki, S. M., Stevens, R. C., Marsillach, J., Richter, R. J., Jarvik, G. P., Checkoway, H., Samii, A., Costa, L. G., Griffith, A., Roberts, J. W., Yearout, D., and Zabetian, C. P. 2010. Human PON1, a biomarker of risk of disease and exposure. Chem. Biol. Interact. 187: 355–361.
   PubMed Web of Science ®Google Scholar
• Geldmacher-von Mallinckrodt, M., and Diepgen, T. 1988. The human serum paraoxonase polymorphysm and specificity. Toxicol. Environ. Chem. 18: 79–196.
   Web of Science ®Google Scholar
• Ginsberg, G., Neafsey, P., Hattis, D., Guyton, K. Z., Johns, D. O., and Sonawane, B. 2009. Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity. J. Toxicol. Environ. Health B 12: 473–507.
   PubMed Web of Science ®Google Scholar
• Ginsberg, G., Sonawane, B., Nath, R., and Lewandowski, P. 2014. Methylmercury-induced inhibition of paraoxonase-1 (PON1)—Implications for cardiovascular risk. J. Toxicol. Environ. Health A 77: 1004–1023.
   PubMed Web of Science ®Google Scholar
• Hernandez, A. F., Mackness, B., Rodrigo, L., Lopez, O., Pla, A., Gil, F., Durrington, P. N., Pena, G., Parron, T., Serrano, J. L., and Mackness, M. I. 2003. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure. Hum. Exp. Toxicol. 22: 565–574.
   PubMed Web of Science ®Google Scholar
• Hernández, A. F., López, O., Pena, G., Serrano, L. J., Parrón, T., Rodrigo, L., Gil, F., and Pla, A. 2008. Implications of paraoxonase-1 (PON1) activity and polymorphisms on biochemical and clinical outcomes in workers exposed to pesticides. In The paraoxonases: Their role in disease development and xenobiotic metabolism, ed. B. Mackness, M. Mackness, M. Aviram, and G. Paragh, 221–237. Amsterdam, The Netherlands: Springer.
   Google Scholar
• Hofmann, J. N., Keifer, M. C., Checkoway, H., De Roos, A. J., Farin, F. M., Fenske, R. A., Richter, R. J., van Belle, G., and Furlong, C. E. 2010. Biomarkers of sensitivity and exposure in Washington state pesticide handlers. Adv. Exp. Med. Biol. 660: 19–27.
   PubMed Web of Science ®Google Scholar
• Huen, K., Harley, K., Bradman, A., Eskenazi, B., and Holland, N. 2010. Longitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypes. Toxicol. Appl. Pharmacol. 244: 181–189.
   PubMed Web of Science ®Google Scholar
• Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., and Furlong, C. E. 1993. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet 3:73–76.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadistica. 2007. VII Senso Agropecuario y Forestal. http://www.censoagropecuario.cl
   Google Scholar
• Jarvik, G. P., Jampsa, R., Richter, R. J., Carlson, C. S., Rieder, M. J., Nickerson, D. A., and Furlong, C. E. 2003. Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics 13: 291–295.
   PubMedGoogle Scholar
• La Du, B. N., Billecke, S., Hsu, C., Haley, R. W., and Broomfield, C. A. 2001. Serum paraoxonase (PON1) isozymes: The quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals. Drug Metab. Dispos. 29: 566–569.
   PubMed Web of Science ®Google Scholar
• Li, W. F., Costa, L. G., and Furlong, C. E. 1993. Serum paraoxonase status—A major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health 40: 337–346.
   PubMed Web of Science ®Google Scholar
• Li, W. F., Costa, L. G., Richter, R. J., Hagen, T., Shih, D. M., Tward, A., Lusis, A. J., and Furlong, C. E. 2000. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10: 767–779.
   PubMedGoogle Scholar
• Li, A. A., Lowe, K. A., McIntosh, L. J., and Mink, P. J. 2012. Evaluation of epidemiology and animal data for risk assessment: Chlorpyrifos developmental neurobehavioral outcomes. J. Toxicol. Environ. Health B 15: 109–184.
   PubMed Web of Science ®Google Scholar
• Lopez-Flores, I., Lacasana, M., Blanco-Munoz, J., Aguilar-Garduno, C., Sanchez-Villegas, P., Perez-Mendez, O. A., and Gamboa-Avila, R. 2009. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides. Toxicol. Lett. 188: 84–90.
   PubMed Web of Science ®Google Scholar
• Mackenzie Ross, S. J., Brewin, C. R., Curran, H. V., Furlong, C. E., Abraham-Smith, K. M., and Harrison, V. 2010. Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicol. Teratol. 32: 452–459.
   PubMed Web of Science ®Google Scholar
• Mackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D. H., Hill, E., Roberts, C., Durrington, P. N., and Mackness, M. I. 2001. Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype? Arteriosclerosis Thromb. Vasc. Biol. 21: 1451–1457.
   PubMed Web of Science ®Google Scholar
• Mackness, B., Durrington, P., Povey, A., Thomson, S., Dippnall, M., Mackness, M., Smith, T., and Cherry, N. 2003. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics 13: 81–88.
   PubMedGoogle Scholar
• Mackness, B, Durrington, P. N., Boulton, A. J., Hine, D., and Mackness, M. I. 2002. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur. J. Clin. Invest. 32: 259–264.
   PubMed Web of Science ®Google Scholar
• Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., and Durrington, P. N. 1998. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett. 423: 57–60.
   PubMed Web of Science ®Google Scholar
• Marquez, C., Villalobos, C., Poblete, S., Villalobos, E., Garcia, M. D., and Duk, S. 2005. Cytogenetic damage in female Chilean agricultural workers exposed to mixtures of pesticides. Environ. Mol. Mutagen. 45: 1–7.
   PubMed Web of Science ®Google Scholar
• Mueller, R. F., Hornung, S., Furlong, C. E., Anderson, J., Giblett, E. R., and Motulsky, A. G. 1983. Plasma paraoxonase polymorphism: A new enzyme assay, population, family, biochemical, and linkage studies. Am. J. Hum. Genet. 35: 393–408.
   PubMed Web of Science ®Google Scholar
• Nguyen, S. D., and Sok, D. E. 2003. Beneficial effect of oleoylated lipids on paraoxonase 1: Protection against oxidative inactivation and stabilization. Biochem. J. 375: 275–285.
   PubMed Web of Science ®Google Scholar
• Pancetti, F., Ramírez, M., and Castillo, C. 2011. Epidemiological studies of anticholinestarase pesticides poisoning in Chile. In Anticholinesterase pesticides: Metabolism, neurotoxicity, and epidemiology, ed. T. Satoh and R. C. Gupta, 357–363. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Richter, R. J., and C. E. Furlong. 1999. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 9: 745–753.
   PubMedGoogle Scholar
• Rojas-Garcia, A. E., Solis-Heredia, M. J., Pina-Guzman, B., Vega, L., Lopez-Carrillo, L., and Quintanilla-Vega, B. 2005. Genetic polymorphisms and activity of PON1 in a Mexican population. Toxicol. Appl. Pharmacol. 205: 282–289.
   PubMed Web of Science ®Google Scholar
• Roy, A. C., Saha, N., Tay, J. S., and Ratnam, S. S. 1991. Serum paraoxonase polymorphism in three populations of southeast Asia. Hum. Hered. 41: 265–269.
   PubMed Web of Science ®Google Scholar
• Scacchi, R., Corbo, R. M., Rickards, O., and De Stefano, G. F. 2003. New data on the world distribution of paraoxonase (PON1 Gln 192 → Arg) gene frequencies. Hum. Biol. 75: 365–373.
   PubMed Web of Science ®Google Scholar
• Servicio Agrícola y Ganadero. 2001. Declaración de ventas de plaguicidas de uso agrícola año 2001. Sub-Departamento de Plaguicidas y Fertilizantes. Ministry of Agriculture. Chile (www.sag.gob.cl).
   Google Scholar
• Servicio Agricola y Ganadero. 2008. Declaración de ventas de plaguicidas de uso agrícola año 2008. Sub-Departamento de Plaguicidas y Fertilizantes. Ministry of Agriculture. Chile (www.sag.gob.cl).
   Google Scholar
• Sozmen, E. Y., Mackness, B., Sozmen, B., Durrington, P., Girgin, F. K., Aslan, L., and Mackness, M. 2002. Effect of organophosphate intoxication on human serum paraoxonase. Hum. Exp. Toxicol. 21: 247–252.
   PubMed Web of Science ®Google Scholar
• Teiber, J. F., Kramer, G. L., and Haley, R. W. 2013. Methods for measuring serum activity levels of the 192 Q and R isoenzymes of paraoxonase 1 in QR heterozygous individuals. Clin. Chem. 59: 1251–1259.
   PubMed Web of Science ®Google Scholar
• Vakonaki, E., Androutsopoulos, V. P., Liesivuori, J., Tsatsakis, A. M., and Spandidos, D. A. 2013. Pesticides and oncogenic modulation. Toxicology 307: 42–45.
   PubMed Web of Science ®Google Scholar